Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:22 AM
Ignite Modification Date:
2025-12-25 @ 3:22 AM
NCT ID:
NCT04599205
Eligibility Criteria:
Inclusion Criteria:
* \- Gender: Only female patients.
* Age: 18-50 years old.
* Type of melasma: Bilateral symmetrical facial melasma of all types.
* Fitzpatrick skin phototypes: Types III, IV and V.
Exclusion Criteria:
* \- Pregnancy and lactation.
* Patients taking oral contraceptive pills, hormonal replacement therapy or isotretinoin at the time of the study or during the past 6 months. Concomitant use of anticoagulants, bleeding disorders.
* Scarring and keloid tendency, active skin infections, active HSV, and those with facial cancer.
* History of photosensitivity or photosensitizing medications such as sulfonamides and tetracycline.
* Previous history of post inflammatory hyperpigmentation.
Healthy Volunteers:
True
Sex:
FEMALE
Minimum Age:
18 Years
Maximum Age:
50 Years
Study:
NCT04599205
Study Brief:
Protocol Section:
NCT04599205